The Totally Civil Covid Thread. (Closing 31/05)

  • Vitamin D supplements can help protect patients with new COVID-19 strain


    Vitamin D supplements can help protect patients with new COVID-19 strain
    The probability of death was found to be higher by as much as 50% in COVID patients with severe vitamin D deficiency, while this probability fell to 5% in…
    m.jpost.com


    The probability of death was found to be higher by as much as 50% in COVID patients with severe vitamin D deficiency, while this probability fell to 5% in patients with good levels of the vitamin.

    Vitamin D supplementation has been found by researchers in Israel and Russia to improve immune function in COVID-19 patients – and is thus recommended for them, as well as for healthy people.

  • Hair and Libido Loss Join Fatigue and Brain Fog Among Wider List of Long COVID Symptoms


    Hair and Libido Loss Join Fatigue and Brain Fog Among Wider List of Long COVID Symptoms - Neuroscience News
    Sexual dysfunction and hair loss are being reported as additional symptoms long-COVID patients experience, a new study reports.
    neurosciencenews.com


    Summary: Sexual dysfunction and hair loss are being reported as additional symptoms long-COVID patients experience, a new study reports.


    Source: University of Birmingham


    Long Covid sufferers have experienced a wider set of symptoms than previously thought including hair loss and sexual dysfunction, new research has found.


    A study published in Nature Medicine today found that patients with a primary care record of infection with the virus that causes Covid-19 (SARS-CoV-2 coronavirus) reported 62 symptoms much more frequently 12 weeks after initial infection than those who hadn’t contracted the virus.



    How Can Something As Simple As Thiamine Cause So Many Problems?

    How Can Something As Simple As Thiamine Cause So Many Problems?- Hormones Matter
    Is thiamine deficiency too simple to explain the devastating nature of the systemic adverse reactions to some vaccines and medications?
    www.hormonesmatter.com


    Understanding Thiamine’s Role in Complex Adverse Reactions – The Limbic System

    The lower part of the brain, called the brainstem, is a like computer, controlling the most basic aspects of survival, from breathing and heart rate, hunger and satiety, to fight or flight and reproduction. This computer-like function within the brainstem is called the autonomic system (ANS). The ANS together with the limbic system act in concert to regulate our most basic survival functions and behaviors. Both require thiamine to function.

  • A study published in Nature Medicine today found that patients with a primary care record of infection with the virus

    Yes! Please read primary care record = sever symptoms else you don't consult a doctor like 90..95 of all CoV-19 cases do. My hair loss started some ten years ago. Is this now the proof that Covid is much older???

  • Yes! Please read primary care record = sever symptoms else you don't consult a doctor like 90..95 of all CoV-19 cases do. My hair loss started some ten years ago. Is this now the proof that Covid is much older???

    No it means you probably had a shitty diet, now if you had limp dick for ten years along with balding you might be on to something

  • As usual. We Swiss are after the money. Less hair on head less to pay for hair dresser...shampoo...But needs as a sunhat for walking else skin cancer may be...

    It's evolutionary progress

    Good sense of humor but remember the old saying, you are what you eat. Coronary disease runs in my family. 100% Irish decent, meat and potatoes some veggie on the side. It's not bad genes, it's poor choices made in the wood pile, starting with diet.

  • Canadian military will soon end vaccine mandate

    Service members will no longer have to attest to their vaccine status and new recruits will no longer have to be fully vaccinated to enrol in the Canadian Armed Forces.


    Canadian Forces members discharged from service because they disobeyed an order to get vaccinated against COVID-19 will have the opportunity to re-enrol, according to leaked details of the military’s revised vaccination policy.

  • I like Japanese food. Tons of fish may 2 times meat a week, May be I'm low on B12..

    I get 2 B12 shots each year. If you ever suffer stomach ailments you probably should supplement a B complex.

    My diet resembles yours, fish 4-5 times a week, red meat maybe once every two weeks for iron. Fruits and nuts during the day, no alcohol, no sugar and limit myself on salt, and only home squeezed juice or water. I quit smoking a few years back and my only indulgence is smoking a fatty after dinner, to keep Covid away ;)

  • "The two teams of researchers, from London and Glasgow, say infants exposed later than normal - because of Covid restrictions - missed out on some early immunity to:

    Adeno-associated virus 2 infection in children with non-A-E hepatitis
    An outbreak of acute hepatitis of unknown aetiology in children was first reported in Scotland in April 2022.[1][1] Cases aged <16 years have since been…
    www.medrxiv.org


    Some details about the hepatitis... and it looks like new vaccines are based - now tested - that use the AAVxy virus as a vector....

  • The Missing Third Death from Pfizer-BioNTech’s Pivotal Article and a Further Look at the ‘Non-Related’ Adverse Events


    The Missing Third Death from Pfizer-BioNTech’s Pivotal Article and a Further Look at the ‘Non-Related’ Adverse Events
    On 10 Dec 2020, a pivotal article by Polack et al, entitled Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine was published in the New England Journal…
    www.trialsitenews.com


    On 10 Dec 2020, a pivotal article by Polack et al, entitled Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine was published in the New England Journal of Medicine(NEJM). The Pfizer and BioNTech supported report with its authors affiliated to those companies, paved the way for the FDA to grant EUA (emergency use authorisation) of BNT162b2 mRNA vaccine for those aged 16 years and above, the very next day.


    It was the first time in history an experimental mRNA-based gene therapy product was sanctioned for use in the general population, for both the sick and the healthy.


    The report analysed the results of the ‘ongoing multinational, placebo-controlled, observer-blinded, pivotal efficacy trial’ and concluded, ‘A two-dose regimen of BNT162b2 conferred 95% protection against Covid-19 in persons 16 years of age or older. Safety over a median of 2 months was similar to that of other viral vaccines. (Funded by BioNTech and Pfizer)’


    According to the report, ‘Two BNT162b2 recipients died (one from arteriosclerosis, one from cardiac arrest), as did four placebo recipients (two from unknown causes, one from hemorrhagic stroke, and one from myocardial infarction). No deaths were considered by the investigators to be related to the vaccine or placebo. No Covid-19–associated deaths were observed.’


    My July 12 article for Trial Site News was the first to report on the recently disclosed 3000+ page Pfizer document entitled C4591001-fa-interim-narrative-sensitive. Since then, other media outlets have reported on this controversial document. My investigative report formed the basis of a Daily Sceptics article, which triggered a temporary suspension of the publication’s Twitter account when they posted it on the social media platform.


    Several concerning issues were raised in my report: firstly, the three vaccine recipient deaths, which Pfizer did not even attempt to investigate but instead swiftly denied any possibility of vaccine causality. Secondly, the ‘related’ and multitiude of ‘not-related’ serious adverse events reported in the document, which Pfizer denied having any relation to the vaccine, even when the trial investigator or hospital oncologist, believed the vaccine was related to a particular adverse event.


    However, what is most unusual, is the fact the third vaccine recipient’s death, which I sourced from Pfizer's own document and noted in my report, was never included in the landmark article published in the NEJM. I am referring to the death of subject #11521497. Only two deaths were mentioned in the article by Polack et al (both were accounted for in my report):


    Death from arteriosclerosis of subject # 11621327, a 60-year-old male

    Death from cardiac arrest of subject # 10071101, a 56-year-old female

    There is no mention of the death of subject #11521497, a 72-year-old male who received the first vaccine dose on 7 October, 2020. He missed the second dose because he failed to show up for ‘Visit 2’ because he was admitted to hospital on 26 October, having ‘fainted in the middle of the night’ due to a vasovagal syncope. The site was informed of this subject’s death by the subject's sister who ‘confirmed the subject died on 11 Nov 2020. The cause of death was reported as unknown.’


    Instead of ‘death’ being noted as the reason(s) for narrative like the other two who died, this subject's records read, ‘Safety-Related Subject Withdrawal.’ Shockingly, it’s not even classified as a death, even though the subject did indeed die a month after receiving the vaccine.




    Two facts are irrefutable here: Pfizer’s US trial site #1152 was made aware of this subject’s death, since it’s stated in their ‘sensitive’ document. Secondly, this man was a vaccine recipient. This then begs the questions: why was his death not included in the NEJM article and why was his death not even classified as a 'death' in the original Pfizer document? The omission of a 50% increase in vaccine recipient deaths is highly concerning and Pfizer needs to address these very valid questions. A right of reply was extended to Pfizer concerning these issues but at the time this article was published, no response was received. This report will be updated if a response becomes available.


    There is another serious anomaly which has arisen from the recently disclosed ‘narrative-sensitive’ document and confirmed by the report published in the NEJM, which stated ‘Four related serious adverse events were reported among BNT162b2 recipients (shoulder injury related to vaccine administration, right axillary lymphadenopathy, paroxysmal ventricular arrhythmia, and right leg paresthesia).'


    My previous report analysed the ‘four related serious adverse events’ and looked into the ‘non-related’ serious adverse events. What’s highly questionable, is why only four events were categorised as related (according to the trial investigator, not by Pfizer, who did not consider any event to be related) but the remaining cases were simply classified as either ‘non-related’ or as ‘other.’


    Below is a list of the many serious adverse event cases, where no reason is given, other than the reason of, ‘no reasonable possibility’ in explaining why they could not possibly be related to the vaccine:


    Subject #11161059, 20-year-old female suffers from bile duct stone, 13 days after dose 1


    Subject #11241106, 40-year-old male suffers from heart attack, 11 days after dose 2


    Subject #11281103, 48-year-old female suffers from nephrolithiasis, low blood potassium, 32 days after dose 2.


    Subject #11291074, 84-year-old male suffers from worsened vertigo and double vision, 11 days after dose 1


    Subject #11421044, 73-year-old female suffers from colitis, 7 days after dose 2


    Subject #11461200, 51-year-old male suffers from acute bradycardia and loss of consciousness, 2 days after dose 2


    Subject #11461264, 58-year-old male suffers from pulmonary embolism, 25 days after dose 2


    Subject #11501001, 45-year-old male suffers from worsening pancreatitis, 4 days after dose 1


    Subject #11561006, 45-year-old male suffers from deep vein thrombosis, 11 days after dose 1


    Subject # 11671175, 55-year-old male suffers from stroke, 22 days after dose 2


    Subject #11781015, 67-year-old male suffers from transient global amnesia, 25 days after dose 2


    Subject #11781025, 79-year-old female suffers from nephrolithiasis, 3 days after dose 2


    Subject 11781167, 68-year-old male suffers from cholelithiasis, 4 days after dose 2


    Subject #12231159, 73-year-old female suffers from pancreatic mass, 35 days after dose 2


    Subject #12261282, 35-year-old male suffers from appendicitis, 21 days after dose 2


    Subject #11521476, 61-year-old female suffers from unilateral deafness, 19 days after dose 1


    Subject #11121118, 56-year-old female suffers from pruritus and tachycardia, 1 days after dose 1

  • The Missing Third Death from Pfizer-BioNTech’s Pivotal Article and a Further Look at the ‘Non-Related’ Adverse Events

    This is just another way they cheat : If you don't make it to completion through the trial, due to (say) injury or death, you're not included in the official results.

  • FLCCC’s Omicron (BA.4/BA.5) Treatment Protocols


    FLCCC’s Omicron (BA.4/BA.5) Treatment Protocols
    The organization, &lsquo;Front Line COVID-19 Critical Care Alliance (FLCCC)&rsquo; formed by critical care specialists, has prepared a COVID-19 treatment…
    www.trialsitenews.com


    The organization, ‘Front Line COVID-19 Critical Care Alliance (FLCCC)’ formed by critical care specialists, has prepared a COVID-19 treatment protocol for professional healthcare providers. The protocol was devised by Dr. Flavio Cadegiani from Brazil and Dr. Robert Rapiti from South Africa, who have both been successful in their treatment of patients affected by the virus. As the new Omicron BA.4/BA.5 strains are rapidly spreading, especially in the U.S., Brazil, and South Africa, Dr. Flavio and Dr. Rapiti emphasize the early and aggressive treatment of the COVID-19 viral infection with antibiotics and steroids. These healthcare providers discussed the treatment protocols in the FLCCC’s Weekly Webinar on June 29.


    We emphasize here that TrialSite News exists as a critical media monitoring medical research related news, and that readers should consult their physician/licensed healthcare provider for any treatment regimens in their local jurisdiction for COVID or any other condition.


    Conditions in Brazil

    Talking about the situation in Brazil, Dr. Flavio explained that earlier Omicron strains were mild, but when it comes to BA.5, a much higher inflammatory response is seen, with 30-50% of the patients getting a secondary bacterial infection – particularly, upper respiratory infection 9. He believes the reason is prior COVID-19 vaccination and infection resulting in a weakened immune system.


    How is Dr. Flavio treating his patients differently?


    In the webinar, Dr. Flavio says that the secondary bacterial infection occurs between day 5 and day 7 of COVID-19 infection. Before, he did not prescribe antibiotics but now he does. Through this, recovery is becoming faster in almost 100% of cases.


    The Treatment Protocol


    In his treatment protocol, Dr. Flavio mentions the use of hydroxychloroquine or ivermectin along with blood anticoagulants, vitamin C, vitamin D, and zinc.


    Use of blood anticoagulants


    Upon answering questions about the use of anticoagulants, he said that he uses them because almost 100% of infected people come with high fibrinogen (a glycoprotein that circulates in the body and converts to a blood clot after tissue or vascular injury) levels and at least 50% with increased D-dimer (a protein fragment that is formed after the dissolution of a blood clot) levels which indicate a risk of blood coagulation. According to him, nearly everyone in the Brazilian population is vaccinated, so there’s an increased risk of thrombosis.


    A different approach toward vaccinated and unvaccinated patients


    Dr. Paul Marik asked Dr. Flavio if he distinguishes between vaccinated and unvaccinated patients or whether he just gives anticoagulants to all of his patients. Dr. Flavio answered that very few people are unvaccinated. Therefore, his protocol is based on the general assumption that everyone’s vaccinated.


    Dr. Flavio starts the treatment procedure with a glucocorticoid and an antibiotic. When there’s an unvaccinated person, he might treat more aggressively, but he has only received 3 such patients who had very mild symptoms with no abnormalities. They were taking ivermectin irregularly. Out of 120 patients, those who were taking ivermectin with hydroxychloroquine on a weekly basis as a prophylactic treatment, none had COVID-19 since Omicron started.


    Further, he said, “My approach is patient by patient. It is very rare to have exactly the same prescription for two patients. COVID-19 is anything but one-size-fits-all. It’s the disease with the most vulnerable clinical manifestations and clinical severity. It depends more on the host than on the virus, you should never forget that.”


    Situation in South Africa

    Dr. Robert Rapiti was asked about his management of BA.4/5 infections in South Africa. Answering the question, he compared earlier Omicron strains and BA.4/5. He said that with BA.1/2, COVID-19 pneumonia was almost never observed; it was only seen in 7% of the BA1/2 patients. Among the thousands of patients with the Delta strain, pneumonia was observed in 90%. Out of 120 patients with BA.5, 115 had pneumonia.


    The treatment protocol


    Emphasizing early treatment, Dr. Rapiti said that he uses a high dose of steroids and the patients feel better by day 3. He said that he met a 79-year-old female who was having no symptoms other than a cough for which she had been taking cough medicine for 3 weeks. “Now, the big pharma must be very happy for pushing all the rubbish to her throat”, he said. According to him, the reason for the cough was that there is some healthy lung tissue that compensates for the entire bad lung, even with 96% oxygen saturation and shortness of breath, the healthy lung tissue is making up for the bad lung.


    The use of supplemental oxygen depends on several factors, like which COVID-19 strain the patient has been infected with. In a patient with 80% oxygen saturation with the Delta variant, supplemental oxygen can be given, but with the Omicron variant and 80% saturation accompanied by anemia, the patient does not need supplemental oxygen.


    He gave his stance that waiting longer in spite of knowing the signs of the disease makes no point, so the steroids and antibiotics have to be started on the first day. He also suggests that keeping the nose clean is another part of the treatment, as it traps the virus.


    Role of COVID-19 diagnostic tests from Dr. Rapiti’s perspective


    Dr. Rapiti said that he does not waste his time with tests, including the PCR test, as he is in a low-income area, and people can’t afford the test. The cost of the PCR test is double the amount he needs to treat them.


    Early treatment procedure


    Dr. Rapiti starts the treatment with 150 mg of aspirin to prevent clotting. When he gets blood results for clotting, if the clotting is under 1000 ng FEU/ml (nanogram fibrinogen equivalent unit per milliliter of blood), he recommends continuing aspirin. If it goes up to 1000-1500, he recommends Clopidogrel because the drug costs are a factor and if it goes 2000 and above, he gives 15 mg Xeralto (Rivaroxaban); if it goes up to 3000-4000, he gives 40 mg of Clexane twice a day subcutaneously.


    According to him, undertreatment by not giving anticoagulants might pose a risk for stroke. If the anticoagulant is used early, its administration can be stopped at any time.


    Using two antibiotics


    Dr. Paul Marick asked Rapiti, “We see you are using two antibiotics, erythromycin and doxycycline. Is there a reason for that?” He answered, “Time is of the essence here. I won’t wait for the bacterial infection to come back. I use erythromycin because it has antiviral properties. Doxycycline is a zinc ionophore. If you use zinc, doxycycline will help zinc to be transported to the cell. I hit the disease from every angle so I spare no enemies.”


    Using black seed


    Dr. Rapiti recommends the use of Nigella sativa or Black Seed. He said that there was a study in Pakistan where they used Nigella sativa. Nigella sativa showed better results than ivermectin and remdesivir, in terms of recovery rate, hospitalization complications, and clearing of viral load. Honey enhances the absorption of these seeds so they should be used in combination. “If I have to use one thing as prophylactic, it is Nigella sativa,” he claimed.


    Regarding its safety for use in pregnant women, Dr. Rapiti said that it is totally safe and that he had used it in them earlier with no problems at all.


    A different approach towards vaccinated and unvaccinated patients


    Dr. Rapiti said that he does not distinguish between vaccinated and unvaccinated. He treats his patients based on the symptoms starting with aspirin if the D-dimer is fairly high. He said that 70% of South Africa’s population is unvaccinated and is against vaccination. However, based on statistics provided by the South African government, 50% of the population is fully vaccinated.


    Conclusion

    Dr. Rapiti and Dr. Paul Marik agreed that BA.4/5 strains are very different from the earlier strains, whereas Dr. Rapiti stresses that there’s no such thing as breakthrough infection. According to these doctors, the vaccines will not work against these strains. Also, Dr. Rapiti does not differentiate between vaccinated and unvaccinated patients, he goes by the clinical symptoms. Dr. Flavio Cadegiani focused on the same, saying that his approach is “patient-by-patient”. Early treatment is, however, the only possible solution in their eyes.

Subscribe to our newsletter

It's sent once a month, you can unsubscribe at anytime!

View archive of previous newsletters

* indicates required

Your email address will be used to send you email newsletters only. See our Privacy Policy for more information.

Our Partners

Supporting researchers for over 20 years
Want to Advertise or Sponsor LENR Forum?
CLICK HERE to contact us.